The first comparative double-blind trial on efficacy and safety of ergotamine based five-component combination and sumatriptan in migraine without aura.

Miljkovic, S; Smajlovic, Dz; Tiric Campara, M; Jurina, R; Duranovic Vinkovic, L; Jankovic, S M; Begovic, B; Ceranic, M

Miljkovic, S; Smajlovic, Dz; Tiric Campara, M; Jurina, R; Duranovic Vinkovic, L; Jankovic, S M; Begovic, B; Ceranic, M.

Afiliação

Miljkovic S; Department of Neurology, University Clinical Center Banja Luka, Bosnia and Herzegovina.
Smajlovic D; Department of Neurology, University Clinical Center Tuzla, Bosnia and Herzegovina.
Tiric Campara M; Department of Neurology, University Clinical Center Sarajevo, Bosnia and Herzegovina.
Jurina R; Department of Neurology, University Clinical Hospital Mostar, Bosnia and Herzegovina.
Duranovic Vinkovic L; Department of Neurology, Cantonal Hospital "Dr. Safet Mujic" Mostar (Regional Medical Center), Bosnia and Herzegovina.
Jankovic SM; Faculty of Medical Science, University of Kragujevac, Serbia.
Begovic B; Society for Pharmacoeconomics and Outcomes Research in Bosnia and Herzegovina, ISPOR Regional Chapter, Bosnia and Herzegovina.
Ceranic M; Bosnalijek dd, Sarajevo, Bosnia and Herzegovina.

Hippokratia ; 22(1): 17-22, 2018.

Article em En | MEDLINE | ID: mdl-31213753

Palavras-chave

efficacy; ergotamine based fixed drug combinations; migraine without aura; safety; sumatriptan

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies Idioma: En Revista: Hippokratia Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google